Table 5.
Total population (n = 8237) | O20, A5 (patients, n) | O40, A5 (patients, n) | O40, A10 (patients, n) | Total (patients, n) |
Patients without ADR | 4141 | 2472 | 1400 | 8013 |
Patients with ADR | 91 | 54 | 79 | 226* |
Serious | 5 | 4 | 3 | 13 |
Not serious | 86 | 50 | 76 | 213 |
Change in dose* | O20, A5 (n, % of patients with ADRs) | O40, A5 (n, % of patients with ADRs) | O40, A10 (n, % of patients with ADRs) | Total (n, % of patients with ADRs) |
Not changed | 3 (1.33) | 4 (1.78) | 4 (1.78%) | 11 (4.89%) |
Drug withdrawn | 86 (38.22) | 49 (21.78) | 68 (30.22%) | 204 (90.67%)** |
Dose reduced | 1 (0.44) | 1 (0.44) | 6 (2.67%) | 8 (3.56%) |
Dose increased | 1 (0.44) | 0 (0) | 0 (0%) | 1 (0.44%) |
Unknown | 0 (0) | 0 (0) | 1 (0.44%) | 1 (0.44%) |
Notes:
Data from one patient not included;
One patient with unknown dose.
Abbreviation: ADRs, adverse drug reactions.